Related Experiment Video
Updated: Jun 25, 2026

12:48
Construction of Cell-based Neurotransmitter Fluorescent Engineered Reporters CNiFERs for Optical Detection of Neurotransmitters In Vivo
Published on: May 12, 2016
13.3K
Biomimetic Analysis of Neurotransmitters for Disease Diagnosis through Light-Driven Nanozyme Sensor Array and Machine
Kun Yu1, Siyuan Lu2, Kaiwen Qiu2
1Lianyungang Clinical College, Jiangsu University & The Second People's Hospital of Lianyungang, Lianyungang, 222006, P. R. China.
Summary
A new photoresponsive nanozyme sensor array uses metal-organic frameworks and machine learning for fast, sensitive detection of neurotransmitters. This technology aids in the early diagnosis and monitoring of neurological diseases like Alzheimer's disease.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Neuroscience
Background:
- Neurological diseases (e.g., Alzheimer's, Parkinson's) present a global health challenge.
- Disrupted neurotransmitter regulation is a hallmark of these disorders.
- Current diagnostic methods are slow and lack early-stage sensitivity.
Purpose of the Study:
- To develop a novel photoresponsive nanozyme sensor array for rapid, sensitive, and multiplexed neurotransmitter detection.
- To integrate metal-organic frameworks (MOFs) and machine learning for enhanced diagnostic capabilities.
- To enable early diagnosis and continuous monitoring of neurological conditions.
Main Methods:
- Fabrication of a photoresponsive nanozyme sensor array using Zn(II) meso-Tetra(4-carboxyphenyl)porphine (ZnTCPP)-based MOFs.
- Utilizing light-driven catalysis to accelerate nanozyme response speed.
- Employing machine learning algorithms for patterned neurotransmitter detection and analysis, mimicking the mammalian olfactory system.
Main Results:
- The sensor array demonstrated rapid and sensitive detection of neurotransmitters within minutes.
- High precision was maintained even in complex biological samples (serum, cerebrospinal fluid).
- The system successfully detected neurotransmitter signatures associated with neurological disorders, including Alzheimer's disease.
Conclusions:
- The novel photoresponsive nanozyme sensor array offers a significant advancement in neurological disease diagnostics.
- This biomimetic platform provides potential for early detection and ongoing monitoring of conditions like Alzheimer's disease.
- The integration of MOFs and machine learning facilitates accurate neurotransmitter analysis in complex biological matrices.

